TNFRSF10A and Miyoshi myopathy: Taken together, these data indicate that upon bortezomib exposure, the most important and significant difference is, unlike the cells without the deletion, MM cells carrying del(8)(p21) fail to upregulate the pro-apoptotic TRAIL-R1.